We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The regulators have also permitted manufacturing at risk and stockpiling doses even before approval so that they can be rolled out into the immunisation programme without any time lag, she said.
India’s vaccine endeavour in fighting the novel coronavirus can truly be termed ‘vaccineyaan’ because it is going all over the world, said Department of Biotechnology Secretary Renu Swarup.